Control of arteriovenous shunt flow.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001158:Arteries / Q000187:drug effects; D001166:Arteriovenous Shunt, Surgical; D001783:Blood Flow Velocity; D001794:Blood Pressure; D002302:Cardiac Output; D003080:Cold Temperature; D003250:Constriction / Q000187:drug effects; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006801:Humans; D008297:Male; D005082:Physical Exertion; D011187:Posture; D006435:Renal Dialysis; D013566:Sympathomimetics / Q000494:pharmacology; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014680:Veins / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D013566:Sympathomimetics; D014662:Vasoconstrictor Agents; D000804:Angiotensin II; D004837:Epinephrine